|
1
|
Masters PS: The molecular biology of
coronaviruses. Adv Virus Res. 66:193–292. 2006.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Xu T, Chen C, Zhu Z, Cui M, Chen C, Dai H
and Xue Y: Clinical features and dynamics of viral load in imported
and non-imported patients with COVID-19. Int J Infect Dis.
94:68–71. 2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Wu C, Zhang Z, Mo Y, Wang D, Ning B, Xu P,
Song J, Pei X, Ni X, Zheng Y, et al: Recommendations for control
and prevention of infections for pediatric orthopedics during the
epidemic period of COVID-19. World J Pediatr Surg.
3(e000124)2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Ding J, Fu H, Liu Y, Gao J, Li Z, Zhao X,
Zheng J, Sun W, Ni H, Ma X, et al: Prevention and control measures
in radiology department for COVID-19. Eur Radiol. 30:3603–3608.
2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Li X, Zai J, Zhao Q, Nie Q, Li Y, Foley BT
and Chaillon A: Evolutionary history, potential intermediate animal
host, and cross-species analyses of SARS-CoV-2. J Med Virol.
92:602–611. 2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Chen N, Zhou M, Dong X, Qu J, Gong F, Han
Y, Qiu Y, Wang J, Liu Y, Wei Y, et al: Epidemiological and clinical
characteristics of 99 cases of 2019 novel coronavirus pneumonia in
Wuhan, China: a descriptive study. Lancet. 395:507–513.
2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Zhou P, Yang XL, Wang XG, Hu B, Zhang L,
Zhang W, Si HR, Zhu Y, Li B, Huang CL, et al: A pneumonia outbreak
associated with a new coronavirus of probable bat origin. Nature.
579:270–273. 2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Devaux CA, Rolain JM, Colson P and Raoult
D: New insights on the antiviral effects of chloroquine against
coronavirus: What to expect for COVID-19? Int J Antimicrob Agents.
55(105938)2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Zheng J: SARS-CoV-2: An emerging
coronavirus that causes a global threat. Int J Biol Sci.
16:1678–1685. 2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Li X, Liu M, Zhao Q, Liu R, Zhang H, Dong
M, Xu S, Liu J, Zhao H, Wei S, et al: Preliminary recommendations
for lung surgery during COVID-19 epidemic period. Thorac Cancer.
11:1372–1374. 2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Yang Y, Peng F, Wang R, Yange M, Guan K,
Jiang T, Xu G, Sun J and Chang C: The deadly coronaviruses: The
2003 SARS pandemic and the 2020 novel coronavirus epidemic in
China. J Autoimmun. 109(102434)2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Tang N, Li D, Wang X and Sun Z: Abnormal
coagulation parameters are associated with poor prognosis in
patients with novel coronavirus pneumonia. J Thromb Haemost.
18:844–847. 2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Ge H, Wang X, Yuan X, Xiao G, Wang C, Deng
T, Yuan Q and Xiao X: The epidemiology and clinical information
about COVID-19. Eur J Clin Microbiol Infect Dis. 39:1011–1019.
2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Suleyman G, Fadel RA, Malette KM, Hammond
C, Abdulla H, Entz A, Demertzis Z, Hanna Z, Failla A, Dagher C, et
al: Clinical characteristics and morbidity associated with
coronavirus disease 2019 in a series of patients in metropolitan
detroit. JAMA Netw Open. 3(e2012270)2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
National Health Commission of People's
Republic of China. Diagnosis and treatment of pneumonia caused by
novel coronavirus (trial version 7).
|
|
16
|
Huang Z, Zhuang D, Xiong B, Deng DX, Li H
and Lai W: Occupational exposure to SARS-CoV-2 in burns treatment
during the COVID-19 epidemic: Specific diagnosis and treatment
protocol. Biomed Pharmacother. 127(110176)2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Liu K, Fang YY, Deng Y, Liu W, Wang MF, M
JP, Xiao W, Wang YN, Zhong MH, Li CH, et al: Clinical
characteristics of novel coronavirus cases in tertiary hospitals in
Hubei Province. Chin Med J (Engl). 133:1025–1031. 2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Lo IL, Lio CF, Cheong HH, Lei CI, Cheong
TH, Zhong X, Tian Y and Sin NN: Evaluation of SARS-CoV-2 RNA
shedding in clinical specimens and clinical characteristics of 10
patients with COVID-19 in Macau. Int J Biol Sci. 16:1698–1707.
2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Bhatraju PK, Ghassemieh BJ, Nichols M, Kim
R, Jerome KR, Nalla AK, Greninger AL, Pipavath S, Wurfel MM, Evans
L, et al: Covid-19 in critically Ill patients in the seattle
region-Case series. N Engl J Med. 382:2012–2022. 2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Spiezia L, Boscolo A, Poletto F, Cerruti
L, Tiberio I, Campello E, Navalesi P and Simioni P:
COVID-19-related severe hypercoagulability in patients admitted to
intensive care unit for acute respiratory failure. Thromb Haemost.
120:998–1000. 2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu
Y, Zhang L, Fan G, Xu J, Gu X, et al: Clinical features of patients
infected with 2019 novel coronavirus in Wuhan, China. Lancet.
395:497–506. 2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Interpretation of the diagnosis and
treatment plan of corona virus disease 2019 (tentative fifth
revised edition). Glob Health J 4: 6-8 2020. Published online 2020
Mar 17. doi: 10.1016/j.glohj.2020.03.002.
|
|
23
|
Li Y and Xia LM: Coronavirus disease 2019
(COVID-19): Role of chest CT in diagnosis and management. AJR Am J
Roentgenol. 214:1280–1286. 2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Yang WJ and Yan FH: Patients with
RT-PCR-confirmed COVID-19 and normal chest CT. Radiology.
295(E3)2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Tahamtan A and Ardebili A: Real-time
RT-PCR in COVID-19 detection: Issues affecting the results. Expert
Rev Mol Diagn. 20:453–454. 2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Chan JF, Yip CC, To KK, Tang TH, Wong SC,
Leung KH, Fung AY, Ng AC, Zou Z, Tsoi HW, et al: Improved molecular
diagnosis of COVID-19 by the novel, highly sensitive and specific
COVID-19-RdRp/Hel real-time reverse transcription-PCR assay
validated in vitro and with clinical specimens. J Clin Microbiol.
58:e00310–e00320. 2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Tang YW, Schmitz JE, Persing DH and
Stratton CW: Laboratory diagnosis of COVID-19: Current issues and
challenges. J Clin Microbiol. 58:e00512–e00520. 2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Zhang Y, Shen H, Wang X, Shi X, Li Y, Yan
J, Chen Y and Gu B: Different longitudinal patterns of nucleic acid
and serology testing results based on disease severity of COVID-19
patients. Emerg Microbes Infect. 9:833–836. 2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Jean SS, Lee PI and Hsueh PR: Treatment
options for COVID-19: The reality and challenges. J Microbiol
Immunol Infect. 53:436–443. 2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Cortegiani A, Ippolito M, Ingoglia G,
Iozzo P, Giarratano A and Einav S: Update I. A systematic review on
the efficacy and safety of chloroquine/hydroxychloroquine for
COVID-19. J Crit Care. 59:176–190. 2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Zhai P, Ding YB, Wu X, Long JK, Zhong YJ
and Li YM: The epidemiology, diagnosis and treatment of COVID-19.
Int J Antimicrob Agents. 55(105955)2020.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Ren JL, Zhang AH and Wang XJ: Traditional
Chinese medicine for COVID-19 treatment. Pharmacol Res.
155(104743)2020.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Taxonera C, Sagastagoitia I, Alba C, Mañas
N, Olivares D and Rey E: 2019 novel coronavirus disease (COVID-19)
in patients with inflammatory bowel diseases. Aliment Pharmacol
Ther. 52:276–283. 2020.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Russell CD, Millar JE and Baillie JK:
Clinical evidence does not support corticosteroid treatment for
2019-nCoV lung injury. Lancet. 395:473–475. 2020.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Goh KJ, Choong MC, Cheong EH, Kalimuddin
S, Duu Wen S, Phua GC, Chan KS and Haja Mohideen S: Rapid
progression to acute respiratory distress syndrome: Review of
current understanding of critical illness from COVID-19 infection.
Ann Acad Med Singap. 49:108–118. 2020.PubMed/NCBI
|
|
36
|
Zhan WQ, Li MD, Xu M and Lu YB: Successful
treatment of COVID-19 using extracorporeal membrane oxygenation, a
case report. Eur Rev Med Pharmacol Sci. 24:3385–3389.
2020.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Solaimanzadeh I: Acetazolamide, nifedipine
and phosphodiesterase inhibitors: Rationale for their utilization
as adjunctive countermeasures in the treatment of coronavirus
disease 2019 (COVID-19). Cureus. 12(e7343)2020.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Bloch EM, Shoham S, Casadevall A, Sachais
BS, Shaz B, Winters JL, van Buskirk C, Grossman BJ, Joyner M,
Henderson JP, et al: Deployment of convalescent plasma for the
prevention and treatment of COVID-19. J Clin Invest. 130:2757–2765.
2020.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Malik YA: Properties of coronavirus and
SARS-CoV-2. Malays J Pathol. 42:3–11. 2020.PubMed/NCBI
|
|
40
|
Hoffmann M, Hofmann-Winkler H and Pöhlmann
S: Chapter 4 priming time: How cellular proteases arm coronavirus
spike proteins. Springer Science and Business Media LLC, 2018.
|
|
41
|
Li F: Structure, function, and evolution
of coronavirus spike proteins. Annu Rev Virol. 3:237–261.
2016.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Li F: Receptor recognition mechanisms of
coronaviruses: A decade of structural studies. J Virol.
89:1954–1964. 2015.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Yi C, Sun X, Ye J, Ding L, Liu M, Yang Z,
Lu X, Zhang Y, Ma L, Gu W, et al: Key residues of the receptor
binding motif in the spike protein of SARS-CoV-2 that interact with
ACE2 and neutralizing antibodies. Cell Mol Immunol. 17:621–630.
2020.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Ye Q, Wang B and Mao J: The pathogenesis
and treatment of the ‘Cytokine Storm’ in COVID-19. J Infect.
80:607–613. 2020.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Guang C, Phillips RD, Jiang B and Milani
F: Three key proteases-angiotensin-I-converting enzyme (ACE), ACE2
and renin-within and beyond the renin-angiotensin system. Arch
Cardiovasc Dis. 105:373–385. 2012.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Sanders JM, Monogue ML, Jodlowski TZ and
Cutrell JB: Pharmacologic treatments for coronavirus disease 2019
(COVID-19): A review. JAMA. 323(1824)2020.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Cao Y, Liu Y, Shang J, Yuan Z, Ping F, Yao
S, Guo Y and Li Y: Ang-(1-7) treatment attenuates
lipopolysaccharide-induced early pulmonary fibrosis. Lab Invest.
99:1770–1783. 2019.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Tan WSD, Liao W, Zhou S, Mei D and Wong
WF: Targeting the renin-angiotensin system as novel therapeutic
strategy for pulmonary diseases. Curr Opin Pharmacol. 40:9–17.
2018.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Jia H: Pulmonary angiotensin-converting
enzyme 2 (ACE2) and inflammatory lung disease. Shock. 46:239–248.
2016.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Klein N, Gembardt F, Supé S, Kaestle SM,
Nickles H, Erfinanda L, Lei X, Yin J, Wang L, Mertens M, et al:
Angiotensin-(1-7) protects from experimental acute lung injury.
Crit Care Med. 41:e334–e343. 2013.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Nitulescu GM, Paunescu H, Moschos SA,
Petrakis D, Nitulescu G, Ion GND, Spandidos DA, Nikolouzakis TK,
Drakoulis N and Tsatsakis A: Comprehensive analysis of drugs to
treat SARS-CoV-2 infection: Mechanistic insights into current
COVID-19 therapies (Review). Int J Mol Med. 46:467–488.
2020.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Sun ML, Yang JM, Sun YP and Su GH:
Inhibitors of RAS might be a good choice for the therapy of
COVID-19 pneumonia. Zhonghua Jie He He Hu Xi Za Zhi. 43:219–222.
2020.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
53
|
Zhang YM, Yu L, Tang L, Zhu M, Jin Y, Wang
Z and Li L: A promising anti-cytokine-storm targeted therapy for
COVID-19: The artificial-liver blood-purification system.
Engineering (Beijing), March 20, 2020 (Online ahead of print).
|
|
54
|
Academician li lanjuan's team showed
initial results in treating critically ill patients. urihttps://www.takefoto.cn/simplehttps://www.takefoto.cn/.
|
|
55
|
Yang XH, Sun RH, Zhao MY, Chen EZ, Liu J,
Wang HL, Yang RL and Chen DC: Expert recommendations on blood
purification treatment protocol for patients with severe COVID-19.
Chronic Dis Transl Med. 6:106–114. 2020.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Liguoro I, Pilotto C, Bonanni M, Ferrari
ME, Pusiol A, Nocerino A, Vidal E and Cogo P: SARS-COV-2 infection
in children and newborns: A systematic review. Eur J Pediatr.
179:1029–1046. 2020.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Dehelean CA, Lazureanu V, Coricovac D,
Mioc M, Oancea R, Marcovici I, Pinzaru I, Soica C, Tsatsakis AM and
Cretu O: SARS-CoV-2: Repurposed drugs and novel therapeutic
approaches-insights into chemical structure-biological activity and
toxicological screening. J Clin Med. 9(2084)2020.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Saxena SK (ed): Coronavirus disease 2019
(COVID-19). Springer Science and Business Media LLC, 2020.
|
|
59
|
Li H, Wang YM, Xu JY and Cao B: Potential
antiviral therapeutics for 2019 novel coronavirus. Zhonghua Jie He
He Hu Xi Za Zhi. 43:170–172. 2020.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
60
|
Lin L, Lu L, Cao W and Li T: Hypothesis
for potential pathogenesis of SARS-CoV-2 infection-a review of
immune changes in patients with viral pneumonia. Emerg Microbes
Infect. 9:727–732. 2020.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Song JC, Wang G, Zhang W, Zhang Y, Li WQ
and Zhou Z: People's Liberation Army Professional Committee of
Critical Care Medicine, Chinese Society on Thrombosis and
Haemostasis. Chinese expert consensus on diagnosis and treatment of
coagulation dysfunction in COVID-19. Mil Med Res.
7(19)2020.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Baruah V and Bose S:
Immunoinformatics-aided identification of T cell and B cell
epitopes in the surface glycoprotein of 2019-nCoV. J Med Virol.
92:495–500. 2020.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Yang L, Tian D and Liu W: Strategies for
vaccine development of COVID-19. Sheng Wu Gong Cheng Xue Bao.
36:593–604. 2020.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
64
|
Calina D, Docea AO, Petrakis D, Egorov AM,
Ishmukhametov AA, Gabibov AG, Shtilman MI, Kostoff R, Carvalho F,
Vinceti M, et al: Towards effective COVID-19 vaccines: Updates,
perspectives and challenges. Int J Mol Med. 46:3–16.
2020.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Thanh Le T, Andreadakis Z, Kumar A, Gómez
Román R, Tollefsen S, Saville M and Mayhew S: The COVID-19 vaccine
development landscape. Nat Rev Drug Discov. 19:305–306.
2020.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Clinical Trials Arena Inovio commences
Phase I trial of DNA vaccine for Covid-19. urihttps://www.clinicaltrialsarena.com/news/inovio-SARS-COV-2-vaccine-trial/simplehttps://www.clinicaltrialsarena.com/news/inovio-SARS-COV-2-vaccine-trial/.
Accessed April 7, 2020.
|
|
67
|
Zhu L, Xu X, Ma K, Yang J, Guan H, Chen S,
Chen Z and Chen G: Successful recovery of COVID-19 pneumonia in a
renal transplant recipient with long-term immunosuppression. Am J
Transplant. 20:1859–1863. 2020.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Qiao XM, Xu XF, Zi H, Liu GX, Li BH, Du X,
Tian ZH, Liu XY, Luo LS and Wang X: Re-positive cases of nucleic
acid tests in discharged patients with COVID-19: A follow-up study.
Front Med (Lausanne). 7(349)2020.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Zhang YH, Lin DJ, Xiao MF, Wang JC, Wei Y,
Lei ZX, Zeng ZQ, Li L, Li HA and Xiang W: 2019-novel coronavirus
infection in a three-month-old baby. Zhonghua Er Ke Za Zhi.
58(E006)2020.PubMed/NCBI View Article : Google Scholar : (In Chinese)
(Online ahead of print).
|
|
70
|
Cecere TE, Todd SM and Leroith T:
Regulatory T cells in arterivirus and coronavirus infections: Do
they protect against disease or enhance it? Viruses. 4:833–846.
2012.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Channappanavar R, Fett C, Zhao J,
Meyerholz DK and Perlman S: Virus-specific memory CD8 T cells
provide substantial protection from lethal severe acute respiratory
syndrome coronavirus infection. J Virol. 88:11034–11044.
2014.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Chen J, Lau YF, Lamirande EW, Paddock CD,
Bartlett JH, Zaki SR and Subbarao K: Cellular immune responses to
severe acute respiratory syndrome coronavirus (SARS-CoV) infection
in senescent BALB/c mice: CD4+ T cells are important in
control of SARS-CoV infection. J Virol. 84:1289–1301.
2010.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Ng OW, Chia A, Tan AT, Jadi RS, Leong HN,
Bertoletti A and Tan YJ: Memory T cell responses targeting the SARS
coronavirus persist up to 11 years post-infection. Vaccine.
34:2008–2014. 2016.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Chen Z and John Wherry E: T cell responses
in patients with COVID-19. Nat Rev Immunol. 20:529–536.
2020.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Qu R, Ling Y, Zhang YH, Wei LY, Chen X, Li
XM, Liu XY, Liu HM, Guo Z, Ren H and Wang Q: Platelet-to-lymphocyte
ratio is associated with prognosis in patients with coronavirus
disease-19. J Med Virol, March 17, 2020 (Online ahead of
print).
|
|
76
|
Pannull F, Yenull T, Sun P, Gui S, Liang
B, Li L, Zheng D, Wang J, Hesketh RL, Yang L and Zheng C: Time
course of lung changes at chest CT during recovery from coronavirus
disease 2019 (COVID-19). Radiology. 295:715–721. 2020.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Pan F, Ye T, Sun P, Gui S, Liang B, Li L,
Zheng D, Wang J, Hesketh RL, Yang L and Zheng C: Time course of
lung changes on chest CT during recovery from 2019 novel
coronavirus (COVID-19) pneumonia. Radiology.
13(200370)2020.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Lin X, Gong Z, Xiao Z, Xiong J, Fan B and
Liu J: Novel coronavirus pneumonia outbreak in 2019: Computed
tomographic findings in two cases. Korean J Radiol. 21:365–368.
2020.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Li K, Wu J, Wu F, Guo D, Chen L, Fang Z
and Li C: The clinical and chest CT features associated with severe
and critical COVID-19 pneumonia. Invest Radiol. 55:327–331.
2020.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Zhao M, Wang M, Zhang J, Ye J, Xu Y, Wang
Z, Ye D, Liu J and Wan J: Advances in the relationship between
coronavirus infection and cardiovascular diseases. Biomed
Pharmacother. 127(110230)2020.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Tadic M, Cuspidi C, Mancia G, Dell'Oro R
and Grassi G: COVID-19, hypertension and cardiovascular diseases:
Should we change the therapy? Pharmacol Res.
158(104906)2020.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Wu J, Li W, Shi X, Chen Z, Jiang B, Liu J,
Wang D, Liu C, Meng Y, Cui L, et al: Early antiviral treatment
contributes to alleviate the severity and improve the prognosis of
patients with novel coronavirus disease (COVID-19). J Intern Med.
288:128–138. 2020.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Yin L, Mou H, Shao J, Zhu Y, Pang X, Yang
J, Zhang J, Shi W, Yu S and Wang H: Correlation between Heart fatty
acid binding protein and severe COVID-19: A case-control study.
PLoS One. 15(e0231687)2020.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Seitz R and Schramm W: DIC in COVID-19:
Implications for prognosis and treatment? J Thromb Haemost.
18:1798–1799. 2020.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Kostoff RN, Briggs MB, Porter AL, Aschner
M, Spandidos DA and Tsatsakis A: [Editorial] COVID-19:
Post-lockdown guidelines. Int J Mol Med. 46:463–466.
2020.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Iddir M, Brito A, Dingeo G, Fernandez Del
Campo SS, Samouda H, La Frano MR and Bohn T: Strengthening the
immune system and reducing inflammation and oxidative stress
through diet and nutrition: Considerations during the COVID-19
crisis. Nutrients. 12(1562)2020.PubMed/NCBI View Article : Google Scholar
|
